113 related articles for article (PubMed ID: 10587111)
1. Characterisation of 67Ga3+ complexes of triaza macrocyclic ligands: biodistribution and clearance studies.
Prata MI; Santos AC; Geraldes CF; de Lima JJ
Nucl Med Biol; 1999 Aug; 26(6):707-10. PubMed ID: 10587111
[TBL] [Abstract][Full Text] [Related]
2. Structural and in vivo studies of metal chelates of Ga(III) relevant to biomedical imaging.
Prata MI; Santos AC; Geraldes CF; de Lima JJ
J Inorg Biochem; 2000 Apr; 79(1-4):359-63. PubMed ID: 10830889
[TBL] [Abstract][Full Text] [Related]
3. Gallium(III) chelates of mixed phosphonate-carboxylate triazamacrocyclic ligands relevant to nuclear medicine: Structural, stability and in vivo studies.
Prata MIM; André JP; Kovács Z; Takács AI; Tircsó G; Tóth I; Geraldes CFGC
J Inorg Biochem; 2017 Dec; 177():8-16. PubMed ID: 28918355
[TBL] [Abstract][Full Text] [Related]
4. New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III).
Jones-Wilson TM; Motekaitis RJ; Sun Y; Anderson CJ; Martell AE; Welch MJ
Nucl Med Biol; 1995 Oct; 22(7):859-68. PubMed ID: 8547883
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of gallium polyaminothiols (PAT).
John CS; Kinuya S; Minear G; Keast RK; Paik CH
Nucl Med Biol; 1993 Feb; 20(2):217-23. PubMed ID: 8448576
[TBL] [Abstract][Full Text] [Related]
6. Targeting radiopharmaceuticals: comparative biodistribution studies of gallium and indium complexes of multidentate ligands.
Mathias CJ; Sun YZ; Welch MJ; Green MA; Thomas JA; Wade KR; Martell AE
Int J Rad Appl Instrum B; 1988; 15(1):69-81. PubMed ID: 3258304
[TBL] [Abstract][Full Text] [Related]
7. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
[TBL] [Abstract][Full Text] [Related]
8. Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.
Kras EA; Abozeid SM; Eduardo W; Spernyak JA; Morrow JR
J Inorg Biochem; 2021 Dec; 225():111594. PubMed ID: 34517167
[TBL] [Abstract][Full Text] [Related]
9. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ
J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917
[TBL] [Abstract][Full Text] [Related]
10. NOTPME: a 31P NMR probe for measurement of divalent cations in biological systems.
Ramasamy R; Lazar I; Brucher E; Sherry AD; Malloy CR
FEBS Lett; 1991 Mar; 280(1):121-4. PubMed ID: 2009956
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
12. Characterization of (111)In(3+) complexes of DTPA amide derivatives: biodistribution and clearance studied by gamma imaging.
Prata MI; Santos AC; Bligh SW; Chowdhury AH; Geraldes CF; de Lima JJ
Nucl Med Biol; 2000 Aug; 27(6):605-10. PubMed ID: 11056377
[TBL] [Abstract][Full Text] [Related]
13. Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes.
Zhang Z; Lyster DM; Webb GA; Orvig C
Int J Rad Appl Instrum B; 1992 Apr; 19(3):327-35. PubMed ID: 1629022
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
15. 67Ga-9N3 uptake by xenografts of human melanotic melanoma in mice.
Harrison A; Walker CA; Pereira KA; Parker D; Royle L; Matthews RC; Craig AS
Nucl Med Commun; 1992 Sep; 13(9):667-72. PubMed ID: 1448240
[TBL] [Abstract][Full Text] [Related]
16. The influence of the combination of carboxylate and phosphinate pendant arms in 1,4,7-triazacyclononane-based chelators on their 68Ga labelling properties.
Máté G; Šimeček J; Pniok M; Kertész I; Notni J; Wester HJ; Galuska L; Hermann P
Molecules; 2015 Jul; 20(7):13112-26. PubMed ID: 26197305
[TBL] [Abstract][Full Text] [Related]
17. Triaza-based amphiphilic chelators: synthetic route, in vitro characterization and in vivo studies of their Ga(III) and Al(III) chelates.
de Sá A; Prata MI; Geraldes CF; André JP
J Inorg Biochem; 2010 Oct; 104(10):1051-62. PubMed ID: 20656358
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability.
Schiller E; Bergmann R; Pietzsch J; Noll B; Sterger A; Johannsen B; Wunderlich G; Pietzsch HJ
Nucl Med Biol; 2008 Feb; 35(2):227-32. PubMed ID: 18312833
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of 67Ga(3+) complexes with cis,cis-1,3,5-triamino-cyclohexane-N,N',N"-triacetic acid derivatives.
Dadachova E; Park C; Eberly N; Ma D; Paik CH; Brechbiel MW
Nucl Med Biol; 2001 Aug; 28(6):695-701. PubMed ID: 11518651
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
Lancelot E
Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
